USP21 promotes cell proliferation and metastasis through suppressing EZH2 ubiquitination in bladder carcinoma

References

• SylvesterRJNatural history, recurrence, and progression in superficial bladder cancerScientific World Journal200662617262517619739
   PubMed Web of Science ®Google Scholar
• CrawfordJMThe origins of bladder cancerLab Invest200888768669318475256
   PubMed Web of Science ®Google Scholar
• KaufmanDSShipleyWUFeldmanASBladder cancerLancet2009374968523924919520422
   PubMed Web of Science ®Google Scholar
• BellmuntJGuixMNew agents for bladder cancerAnn Oncol201021Suppl 7vii56vii5820943643
   PubMedGoogle Scholar
• ResnickMJChangSSOptimizing outcomes for octogenarians with invasive bladder cancer: one size does not fit allUrol Oncol20133111423544191
   PubMedGoogle Scholar
• HershkoACiechanoverAThe ubiquitin systemAnnu Rev Biochem1998674254799759494
   PubMed Web of Science ®Google Scholar
• SunSCDeubiquitylation and regulation of the immune responseNat Rev Immunol20088750151118535581
   PubMedGoogle Scholar
• CaoJYanQHistone ubiquitination and deubiquitination in transcription, DNA damage response, and cancerFron Oncol2012226
   PubMedGoogle Scholar
• KomanderDClagueMJUrbeSBreaking the chains: structure and function of the deubiquitinasesNat Rev Mol Cell Biol200910855056319626045
   PubMed Web of Science ®Google Scholar
• Reyes-TurcuFEVentiiKHWilkinsonKDRegulation and cellular roles of ubiquitin-specific deubiquitinating enzymesAnnu Rev Biochem20097836339719489724
   PubMed Web of Science ®Google Scholar
• LiMChenDShilohADeubiquitination of p53 by HAUSP is an important pathway for p53 stabilizationNature2002416688164865311923872
   PubMed Web of Science ®Google Scholar
• YuanJLuoKZhangLChevilleJCLouZUSP10 regulates p53 localization and stability by deubiquitinating p53Cell2010140338439620096447
   PubMedGoogle Scholar
• BrummelkampTRNijmanSMDiracAMBernardsRLoss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaBNature2003424695079780112917690
   PubMedGoogle Scholar
• WertzIEO’RourkeKMZhouHDe-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signallingNature2004430700069469915258597
   PubMed Web of Science ®Google Scholar
• TzimasCMichailidouGArsenakisMKieffEMosialosGHatzivassiliouEGHuman ubiquitin specific protease 31 is a deubiquitinating enzyme implicated in activation of nuclear factor-kappaBCell Signal2006181839216214042
   PubMedGoogle Scholar
• SchweitzerKBozkoPMDubielWNaumannMCSN controls NF-kappaB by deubiquitinylation of IkappaBalphaEMBO J20072661532154117318178
   PubMedGoogle Scholar
• EnesaKZakkarMChaudhuryHNF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signalingJ Biol Chem2008283117036704518178551
   PubMedGoogle Scholar
• XuGTanXWangHUbiquitin-specific peptidase 21 inhibits tumor necrosis factor alpha-induced nuclear factor kappaB activation via binding to and deubiquitinating receptor-interacting protein 1J Biol Chem2010285296997819910467
   PubMedGoogle Scholar
• YeYAkutsuMReyes-TurcuFEnchevRIWilkinsonKDKomanderDPolyubiquitin binding and cross-reactivity in the USP domain deubiquitinase USP21EMBO Rep201112435035721399617
   PubMedGoogle Scholar
• NakagawaTKajitaniTTogoSDeubiquitylation of histone H2A activates transcriptional initiation via trans-histone cross-talk with H3K4 di- and trimethylationGenes Dev2008221374918172164
   PubMed Web of Science ®Google Scholar
• ZhangJChenCHouXIdentification of the E3 deubiquitinase ubiquitin-specific peptidase 21 (USP21) as a positive regulator of the transcription factor GATA3J Biol Chem2013288139373938223395819
   PubMedGoogle Scholar
• PengLHuYChenDJiaoSSunSUbiquitin specific peptidase 21 regulates interleukin-8 expression, stem-cell like property of human renal cell carcinomaOncotarget2016727420074201627259257
   PubMedGoogle Scholar
• YuHSimonsDLSegallIPRC2/EED-EZH2 complex is up-regulated in breast cancer lymph node metastasis compared to primary tumor and correlates with tumor proliferation in situPLoS One2012712e5123923251464
   PubMedGoogle Scholar
• YuMAKiangAWang-RodriguezJNicotine promotes acquisition of stem cell and epithelial-to-mesenchymal properties in head and neck squamous cell carcinomaPLoS One2012712e5196723300583
   PubMed Web of Science ®Google Scholar
• Martinez-FernandezMRubioCSegoviaCLopez-CalderonFFDuenasMParamioJMEZH2 in bladder cancer, a promising therapeutic targetInt J Mol Sci20151611271072713226580594
   PubMed Web of Science ®Google Scholar
• WarrickJIRamanJDKaagMEnhancer of zeste homolog 2 (EZH2) expression in bladder cancerUrol Oncol2016346258.e1e6
   PubMedGoogle Scholar
• FanYMaoRYuYUSP21 negatively regulates antiviral response by acting as a RIG-I deubiquitinaseJ Exp Med2014211231332824493797
   PubMedGoogle Scholar
• HerideCRigdenDJBertsoulakiEThe centrosomal deubiquitylase USP21 regulates Gli1 transcriptional activity and stabilityJ Cell Sci2016129214001401327621083
   PubMed Web of Science ®Google Scholar
• PannuJBelleJIForsterMUbiquitin specific protease 21 is dispensable for normal development, hematopoiesis and lymphocyte differentiationPLoS One2015102e011730425680095
   PubMedGoogle Scholar
• DuZTongXYeXCyclin D1 promotes cell cycle progression through enhancing NDR1/2 kinase activity independent of cyclin-dependent kinase 4J Biol Chem201328837266782668723897809
   PubMedGoogle Scholar
• LeontievaOVBlagosklonnyMVCDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: duration of cell cycle arrest and MTOR activity determine geroconversionCell Cycle201312183063306923974099
   PubMed Web of Science ®Google Scholar
• BendrisNLemmersBBlanchardJMCell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitorsCell Cycle201514121786179825789852
   PubMed Web of Science ®Google Scholar